Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2023-05-23
2025-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Across Multiple Types of Sleep Deprivation
NCT04211506
Brain Energy and Cognition
NCT01603550
Chronic Sleep Restriction
NCT01493661
Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-cognitive Performance
NCT00438438
Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans
NCT03576664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
[11C]ER176
Brain PET with \[11C\]ER176. \[11C\]ER176 is a PET ligand that images TSPO.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A body mass index (BMI) below 30.
* Weigh at least 140 lbs
* Females must not be pregnant or nursing, and must be on some form of birth control, if sexually active (e.g., oral contraceptive, condom, intrauterine device, etc.)
* No history of sleeping problems such as insomnia or sleep apnea.
* Test negative for alcohol, nicotine, illegal drugs, and not take certain medications.
* Must not excessively consume alcohol or caffeine.
* Active duty and Federal employees must be on leave during participation.
* No history of heart disease (high blood pressure), neurologic disorder (such as seizures of epilepsy), liver disease, kidney disease, or metabolic disorder or diabetes.
* No history of underlying acute or chronic pulmonary disease requiring daily inhaler use.
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
National Intrepid Center of Excellence
FED
Walter Reed Army Institute of Research (WRAIR)
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samantha Riedy
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walter Reed Army Institute of Research
Silver Spring, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, Russo MB, Balkin TJ. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003 Mar;12(1):1-12. doi: 10.1046/j.1365-2869.2003.00337.x.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MO220146
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2804
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.